TIDMHCM
RNS Number : 4181W
Hutchison China Meditech Limited
23 April 2021
Vesting of awards under the Long Term Incentive Plan
Hong Kong, Shanghai & Florham Park, NJ: Friday, April 23,
2021: Hutchison China MediTech Limited ("HUTCHMED") (Nasdaq/AIM:
HCM) announces that the non-performance based awards granted under
the Long Term Incentive Plan ("LTIP") on April 20, 2020 to the
following persons discharging managerial responsibilities were
vested on April 20, 2021:-
Award Holder Number of American depositary shares ("ADS")
------------------------------------------------------------- --------------------------------------------
Mr Simon To (Executive Director) 2,397(1)
Dr Dan Eldar (Non-executive Director ("NED")) 2,397
Ms Edith Shih (NED) 2,397(2)
Mr Paul Carter (Independent Non-executive Director ("INED")) 2,037
Dr Karen Ferrante (INED) 2,397
Mr Graeme Jack (INED) 2,397
Professor Tony Mok (INED) 2,397
Notes:
(1) Similar to the arrangement for his Director's fees, these
ADSs were not received by Mr Simon To, but were received by or for
the account of his employer, Hutchison Whampoa (China) Limited.
(2) Similar to the arrangement for her Director's fees, these
ADSs were not received by Ms Edith Shih, but were received by or
for the account of her employer, Hutchison International
Limited.
The notifications set out below are provided in accordance with
the requirements of the EU Market Abuse Regulation.
(a) Dr Dan Eldar
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Dr Dan Eldar
--------------------------------------------- ----------------------------------------------
2 Reason for the notification
---------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
--------------------------------------------- ----------------------------------------------
b) Initial notification/Amendment Initial notification
--------------------------------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
--------------------------------------------- ----------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
--------------------------------------------- ----------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the financial instrument, type of ADS each representing five Ordinary Shares of US$0.10
instrument ADS ISIN: US44842L1035
Identification code
------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Vesting of awards granted on April 20, 2020 under
HUTCHMED's LTIP
------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 2,397 ADS
----------
------------------------------------------------------- -------------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 2021-04-20
------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------------------------- -------------------------------------------------------
(b) Mr Paul Carter
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Paul Carter
------------------------------------------- ------------------------------------------------
2 Reason for the notification
---------------------------------------------------------------------------------------------
a) Position/status Independent Non-Executive Director
------------------------------------------- ------------------------------------------------
b) Initial notification/Amendment Initial notification
------------------------------------------- ------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
------------------------------------------- ------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
------------------------------------------- ------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the financial instrument, type of ADS each representing five Ordinary Shares of US$0.10
instrument ADS ISIN: US44842L1035
Identification code
------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Vesting of awards granted on April 20, 2020 under
HUTCHMED's LTIP
------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 2,037 ADS
----------
------------------------------------------------------- -------------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 2021-04-20
------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------------------------- -------------------------------------------------------
(c) Dr Karen Ferrante
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Dr Karen Ferrante
------------------------------------------- ------------------------------------------------
2 Reason for the notification
---------------------------------------------------------------------------------------------
a) Position/status Independent Non-Executive Director
------------------------------------------- ------------------------------------------------
b) Initial notification/Amendment Initial notification
------------------------------------------- ------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
------------------------------------------- ------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
------------------------------------------- ------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the financial instrument, type of ADS each representing five Ordinary Shares of US$0.10
instrument ADS ISIN: US44842L1035
Identification code
------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Vesting of awards granted on April 20, 2020 under
HUTCHMED's LTIP
------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 2,397 ADS
----------
------------------------------------------------------- -------------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 2021-04-20
------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------------------------- -------------------------------------------------------
(d) Mr Graeme Jack
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Graeme Jack
------------------------------------------- ------------------------------------------------
2 Reason for the notification
---------------------------------------------------------------------------------------------
a) Position/status Independent Non-Executive Director
------------------------------------------- ------------------------------------------------
b) Initial notification/Amendment Initial notification
------------------------------------------- ------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
------------------------------------------- ------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
------------------------------------------- ------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the financial instrument, type of ADS each representing five Ordinary Shares of US$0.10
instrument ADS ISIN: US44842L1035
Identification code
------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Vesting of awards granted on April 20, 2020 under
HUTCHMED's LTIP
------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 2,397 ADS
----------
------------------------------------------------------- -------------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 2021-04-20
------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------------------------- -------------------------------------------------------
(e) Professor Tony Mok
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Professor Tony Mok
------------------------------------------- ------------------------------------------------
2 Reason for the notification
---------------------------------------------------------------------------------------------
a) Position/status Independent Non-Executive Director
------------------------------------------- ------------------------------------------------
b) Initial notification/Amendment Initial notification
------------------------------------------- ------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
------------------------------------------- ------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
------------------------------------------- ------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the financial instrument, type of ADS each representing five Ordinary Shares of US$0.10
instrument ADS ISIN: US44842L1035
Identification code
------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Vesting of awards granted on April 20, 2020 under
HUTCHMED's LTIP
------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 2,397 ADS
----------
------------------------------------------------------- -------------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 2021-04-20
------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------------------------- -------------------------------------------------------
About HUTCHMED
HUTCHMED (Nasdaq/AIM: HCM) is an innovative, commercial-stage,
biopharmaceutical company. It is committed to the discovery and
global development and commercialization of targeted therapies and
immunotherapies for the treatment of cancer and immunological
diseases. A dedicated organization of over 1,200 personnel has
advanced ten cancer drug candidates from in-house discovery into
clinical studies around the world, with its first two oncology
drugs now approved and launched. For more information, please
visit: www.hutch-med.com or follow us on LinkedIn .
Forward-Looking Statements
This announcement contains forward-looking statements within the
meaning of the "safe harbor" provisions of the U.S. Private
Securities Litigation Reform Act of 1995. Forward-looking
statements involve risks and uncertainties. Existing and
prospective investors are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
hereof. For further discussion of these and other risks, see
HUTCHMED's filings with the U.S. Securities and Exchange Commission
and on AIM. HUTCHMED undertakes no obligation to update or revise
the information contained in this announcement, whether as a result
of new information, future events or circumstances or
otherwise.
CONTACTS
Investor Enquiries
Mark Lee, Senior Vice President +852 2121 8200
Annie Cheng, Vice President +1 (973) 567 3786
Media Enquiries
Americas - Brad Miles, +1 (917) 570 7340 (Mobile)
Solebury Trout bmiles@troutgroup.com
Europe - Ben Atwell / Alex Shaw, +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile)
FTI Consulting HUTCHMED@fticonsulting.com
Asia - Joseph Chi Lo / Zhou Yi, +852 9850 5033 (Mobile) / +852 97 83 6894 (Mobile)
Brunswick HUTCHMED@brunswickgroup.com
Nominated Advisor
Freddy Crossley / Atholl Tweedie,
Panmure Gordon (UK) Limited +44 (20) 7886 2500
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHPPURWCUPGUAW
(END) Dow Jones Newswires
April 23, 2021 02:00 ET (06:00 GMT)
Hutchison China Meditech (LSE:0J7G)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hutchison China Meditech (LSE:0J7G)
Historical Stock Chart
From Apr 2023 to Apr 2024
